Trade-Ideas: Medtronic (MDT) Is Today's Pre-Market Laggard Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Medtronic ( MDT) as a pre-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Medtronic as such a stock due to the following factors:

  • MDT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $442.2 million.
  • MDT traded 12,985 shares today in the pre-market hours as of 7:43 AM.
  • MDT is down 3.6% today from Friday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MDT with the Ticky from Trade-Ideas. See the FREE profile for MDT NOW at Trade-Ideas

More details on MDT:

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The stock currently has a dividend yield of 1.8%. MDT has a PE ratio of 22.5. Currently there are 11 analysts that rate Medtronic a buy, no analysts rate it a sell, and 6 rate it a hold.

The average volume for Medtronic has been 7.4 million shares per day over the past 30 days. Medtronic has a market cap of $65.2 billion and is part of the health care sector and health services industry. The stock has a beta of 0.87 and a short float of 1.2% with 9.30 days to cover. Shares are up 15.4% year-to-date as of the close of trading on Friday.

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning